Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Pierre Fabre reports hypocholesterolemic organosilanes

April 5, 1996

Vitronectin antagonist from Merck & Co. inhibits bone resorption

April 5, 1996

Cortecs licenses salmon calcitonin to Teva

April 5, 1996

Tsumura Juntendo research into aldose reductase inhibitors

March 15, 1996

AI-401 slated to enter phase II

March 15, 1996

Sankyo reports drugs for diabetes

March 15, 1996

Antidiabetic drugs claimed by Tanabe Seiyaku

March 15, 1996

FDA approves Medtronic's blood processing system

March 15, 1996

New Hemosol division to focus on blood substitutes

March 15, 1996

HemaSure's SteriPath system closer to IDE filing

March 15, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...